Rebeiz AG - Search Results

1

Highlights from the American Heart Association annual scientific sessions 2002: November 17 to 20, 2002.

Dery JP, Hernandez AF, Kay JD, Petersen JL, Rao SV, Rebeiz AG, Singh KP, Donahue MP; American Heart Association. Dery JP, et al. Among authors: rebeiz ag. Am Heart J. 2003 Mar;145(3):554-62. doi: 10.1067/mhj.2003.188. Am Heart J. 2003. PMID: 12660682 No abstract available.

2

Highlights from the American College of Cardiology Annual Scientific Sessions 2003: March 28 to April 2, 2003.

Petersen JL, Dery JP, Fischi MC, Hernandez AF, Hranitzky PM, Rao SV, Rebeiz AG, Singh KP. Petersen JL, et al. Among authors: rebeiz ag. Am Heart J. 2003 Jul;146(1):19-26. doi: 10.1016/S0002-8703(03)00280-1. Am Heart J. 2003. PMID: 12851601 No abstract available.

3

Optimal duration of eptifibatide infusion in percutaneous coronary intervention (an ESPRIT substudy).

Rebeiz AG, Dery JP, Tsiatis AA, O'shea JC, Johnson BA, Hellkamp AS, Pieper KS, Gilchrist IC, Slater J, Muhlestein JB, Joseph D, Kitt MM, Tcheng JE; ESPRIT substudy. Rebeiz AG, et al. Am J Cardiol. 2004 Oct 1;94(7):926-9. doi: 10.1016/j.amjcard.2004.06.030. Am J Cardiol. 2004. PMID: 15464679 Clinical Trial.

4

Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials).

Rebeiz AG, Johanson P, Green CL, Crater SW, Roe MT, Langer A, Giugliano RP, Lincoff AM, Newby LK, Harrington RA, Topol EJ, Califf RM, Wagner GS, Krucoff MW. Rebeiz AG, et al. Am J Cardiol. 2005 Mar 1;95(5):611-4. doi: 10.1016/j.amjcard.2004.10.038. Am J Cardiol. 2005. PMID: 15721101

5

Interventional cardiovascular pharmacotherapy: current issues.

Rebeiz AG, Adams J, Harrington RA. Rebeiz AG, et al. Am J Cardiovasc Drugs. 2005;5(2):93-102. doi: 10.2165/00129784-200505020-00003. Am J Cardiovasc Drugs. 2005. PMID: 15725040 Review.

6

Integrating antithrombin and antiplatelet therapies with early invasive management for non-ST-segment elevation acute coronary syndromes.

Rebeiz AG, Roe MT, Alexander JH, Mahaffey KW, Granger CB, Peterson ED, Califf RM, Harrington RA. Rebeiz AG, et al. Am J Med. 2004 Jan 15;116(2):119-29. doi: 10.1016/j.amjmed.2003.09.028. Am J Med. 2004. PMID: 14715326 Review.

7

Radiocontrast nephropathy: a time for affirmative action.

Rebeiz AG, Kandzari DE, Wang A, Sketch MH Jr. Rebeiz AG, et al. J Invasive Cardiol. 2003 Jan;15(1):23-5. J Invasive Cardiol. 2003. PMID: 12499524 No abstract available.

8

Left main coronary artery-to-pulmonary artery fistula with severe aneurysmal dilatation.

Gandy KL, Rebeiz AG, Wang A, Jaggers JJ. Gandy KL, et al. Among authors: rebeiz ag. Ann Thorac Surg. 2004 Mar;77(3):1081-3. doi: 10.1016/j.athoracsur.2003.05.006. Ann Thorac Surg. 2004. PMID: 14992936

9

Electrocardiography to define clinical status in primary pulmonary hypertension and pulmonary arterial hypertension secondary to collagen vascular disease.

Ahearn GS, Tapson VF, Rebeiz A, Greenfield JC Jr. Ahearn GS, et al. Chest. 2002 Aug;122(2):524-7. doi: 10.1378/chest.122.2.524. Chest. 2002. PMID: 12171826

10

Contrast nephropathy : an evidence-based approach to prevention.

Kandzari DE, Rebeiz AG, Wang A, Sketch MH Jr. Kandzari DE, et al. Among authors: rebeiz ag. Am J Cardiovasc Drugs. 2003;3(6):395-405. doi: 10.2165/00129784-200303060-00003. Am J Cardiovasc Drugs. 2003. PMID: 14728060 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters